Clinical trials
Active, not recruiting Phase 2 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 9 |
| 2016 | 11 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 18 |
| M.D. Anderson Cancer Center | 5 |
| Fred Hutchinson Cancer Center | 2 |
| Academic and Community Cancer Research United | 1 |
| City of Hope Medical Center | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Julie-An M. Talano | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Ronald Paquette | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 33 |
| Lymphoma | 18 |
| Multiple Myeloma | 18 |
| Myelodysplastic Syndromes | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.